生命科学资讯

5 FDA decisions to watch in the first quarter of 2026

An emerging clock mechanism in a hydrozoan jellyfish

AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil

CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma

Assessing Illumina (ILMN) Valuation After The Launch Of Its Connected Multiomics Platform - simplywall.st

Assessing Illumina (ILMN) Valuation After The Launch Of Its Connected Multiomics Platform - simplywall.st

CareDx and 10x Genomics partner on transplant rejection research - Investing.com

C-suite priorities give a sneak peek into AI’s pharma future

5 FDA drug approvals to watch in 2026

New TNFR1 antagonists disclosed in Dana-Farber Cancer Institute patent

Chinese scientists discover new GTPase KRAS mutant inhibitors

Holiday notice

Agilent Technologies, Inc. $A Holdings Decreased by Sivik Global Healthcare LLC - MarketBeat

CareDx, Inc. and 10x Genomics to Launch ImmuneScape - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - marketscreener.com

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Chartmill

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Yahoo Finance

Lilly partners with protein mapping startup InduPro for up to $950M

Hutchmed heats up autoimmune race with phase 3 win, teeing up China filing

GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push

Rakuten Medical raises $100M for photoimmunotherapy platform